On Invalid Date, Korro Bio (NASDAQ: KRRO) reported Q3 2023 earnings per share (EPS) of -$15.50, up 43.64% year over year. Total Korro Bio earnings for the quarter were -$11.61 million. In the same quarter last year, Korro Bio's earnings per share (EPS) was -$27.50.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.